UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

51-year-old patient with recurrent pancreatitis and pathologic findings in plasma

Deutsche medizinische Wochenschrift (1946), 2023-03, Vol.148 (6), p.347

2023

Volltextzugriff (PDF)

A European screening programme for familial hypercholesterolaemia: a call to action

European journal of preventive cardiology, 2024-08, Vol.31 (10), p.1199-1202

2024

Volltextzugriff (PDF)

Pathological phenotypes of LDL particles

European heart journal, 2018-07, Vol.39 (27), p.2574-2576

2018

Volltextzugriff (PDF)

It’s time to personalize and optimize lipid-lowering therapy

European heart journal, 2020-07, Vol.41 (28), p.2629-2631

2020

Volltextzugriff (PDF)

Letter by Weingärtner et al Regarding Article, “Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized, Controlled Trial”

Circulation (New York, N.Y.), 2020-02, Vol.141 (6), p.e65-e66

2020

Volltextzugriff (PDF)

Patient and Physician Reported Perception on Hypercholesterolemia Management in Primary Prevention in Germany: Results from a Nationwide Online Survey

Advances in therapy, 2022-09, Vol.39 (9), p.4315-4329

2022

Volltextzugriff (PDF)

Need to individualise cholesterol-lowering therapy

Heart (British Cardiac Society), 2019-08, Vol.105 (16), p.1291-1292

2019

Volltextzugriff (PDF)

Phytosterols and Cardiovascular Disease

Current atherosclerosis reports, 2021-11, Vol.23 (11), p.68-68, Article 68

2021

Volltextzugriff (PDF)

The emerging concept of “individualized cholesterol-lowering therapy”: A change in paradigm

Pharmacology & therapeutics (Oxford), 2019-07, Vol.199, p.111-116

2019

Volltextzugriff (PDF)

High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation

Metabolic syndrome and related disorders, 2020-05, Vol.18 (4), p.176-185

2020

Volltextzugriff (PDF)

Plant sterol enriched functional food and atherosclerosis

British journal of pharmacology, 2017-06, Vol.174 (11), p.1281-1289

2017

Volltextzugriff (PDF)

Different Perspectives of Patients and Physicians on LDL-C Target Achievement in the Treatment of Hypercholesterolemia: Results on Secondary Prevention from the German PROCYON Survey

Advances in therapy, 2023-02, Vol.40 (2), p.460-473

2023

Volltextzugriff (PDF)

Controversial role of plant sterol esters in the management of hypercholesterolaemia

European heart journal, 2009-02, Vol.30 (4), p.404-409

2009

Volltextzugriff (PDF)

Primary and secondary prevention in hypercholesterolemia: differences relevant to patient care in the PROCYON trial

Deutsche medizinische Wochenschrift (1946), 2023-09, Vol.148 (19), p.e101

2023

Volltextzugriff (PDF)

Intensive lipid-lowering therapy for early achievement of guideline-recommended LDL-cholesterol levels in patients with ST-elevation myocardial infarction (“Jena auf Ziel”)

Clinical research in cardiology, 2023-09, Vol.112 (9), p.1212-1219

2023

Volltextzugriff (PDF)

Analyzing IMPROVE-IT Beyond LDL Cholesterol

Journal of the American College of Cardiology, 2022-02, Vol.79 (4), p.e151-e152

2022

Volltextzugriff (PDF)

Increased cholesterol absorption is associated with In-stent-restenosis after stent implantation for stable coronary artery disease

Steroids, 2022-11, Vol.187, p.109079-109079, Article 109079

2022

Volltextzugriff (PDF)

Lipid-lowering therapy in patients with peripheral artery disease – a call for action: Comment on M. Sagris et al., pp. 198–211

VASA, 2022-07, Vol.51 (4), p.193-195

2022

Volltextzugriff (PDF)

Optimizing Clinical Cardiovascular Outcomes by a Personalized Approach to Add Ezetimibe to a Statin

Journal of the American College of Cardiology, 2020-01, Vol.75 (1), p.128-128

2020

Volltextzugriff (PDF)

Call for an ezetimibe effectiveness test

Atherosclerosis, 2018-11, Vol.278, p.334-334

2018

Volltextzugriff (PDF)

Plant sterols in food: No consensus in guidelines

Biochemical and biophysical research communications, 2014-04, Vol.446 (3), p.811-813

2014

Volltextzugriff (PDF)

Individualized lipid-lowering therapy to further reduce residual cardiovascular risk

The Journal of steroid biochemistry and molecular biology, 2017-05, Vol.169, p.198-201

2017

Volltextzugriff (PDF)

Plant sterols the better cholesterol in Alzheimer's disease? A mechanistical study

The Journal of neuroscience, 2013-10, Vol.33 (41), p.16072-16087

2013

Volltextzugriff (PDF)

Plasma levels of the oxyphytosterol 7α-hydroxycampesterol are associated with cardiovascular events

Atherosclerosis, 2018-12, Vol.279, p.17-22

2018

Volltextzugriff (PDF)

Relationship between cholesterol synthesis and intestinal absorption is associated with cardiovascular risk

Atherosclerosis, 2010-06, Vol.210 (2), p.362-365

2010

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Englisch
(57)
Deutsch
(26)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

51-year-old patient with recurrent pancreatitis and pathologic findings in plasma

A European screening programme for familial hypercholesterolaemia: a call to action

Pathological phenotypes of LDL particles

It’s time to personalize and optimize lipid-lowering therapy

Letter by Weingärtner et al Regarding Article, “Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized, Controlled Trial”

Patient and Physician Reported Perception on Hypercholesterolemia Management in Primary Prevention in Germany: Results from a Nationwide Online Survey

Need to individualise cholesterol-lowering therapy

Phytosterols and Cardiovascular Disease

The emerging concept of “individualized cholesterol-lowering therapy”: A change in paradigm

High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation

Plant sterol enriched functional food and atherosclerosis

Different Perspectives of Patients and Physicians on LDL-C Target Achievement in the Treatment of Hypercholesterolemia: Results on Secondary Prevention from the German PROCYON Survey

Controversial role of plant sterol esters in the management of hypercholesterolaemia

Primary and secondary prevention in hypercholesterolemia: differences relevant to patient care in the PROCYON trial

Intensive lipid-lowering therapy for early achievement of guideline-recommended LDL-cholesterol levels in patients with ST-elevation myocardial infarction (“Jena auf Ziel”)

Analyzing IMPROVE-IT Beyond LDL Cholesterol

Increased cholesterol absorption is associated with In-stent-restenosis after stent implantation for stable coronary artery disease

Lipid-lowering therapy in patients with peripheral artery disease – a call for action: Comment on M. Sagris et al., pp. 198–211

Optimizing Clinical Cardiovascular Outcomes by a Personalized Approach to Add Ezetimibe to a Statin

Call for an ezetimibe effectiveness test

Plant sterols in food: No consensus in guidelines

Individualized lipid-lowering therapy to further reduce residual cardiovascular risk

Plant sterols the better cholesterol in Alzheimer's disease? A mechanistical study

Plasma levels of the oxyphytosterol 7α-hydroxycampesterol are associated with cardiovascular events

Relationship between cholesterol synthesis and intestinal absorption is associated with cardiovascular risk

Suchergebnisse filtern